240 related articles for article (PubMed ID: 19235776)
1. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
[TBL] [Abstract][Full Text] [Related]
2. The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort.
Myles PR; Hubbard RB; Gibson JE; Pogson Z; Smith CJ; McKeever TM
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):697-703. PubMed ID: 19455553
[TBL] [Abstract][Full Text] [Related]
3. Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.
de Groot MC; Klungel OH; Leufkens HG; van Dijk L; Grobbee DE; van de Garde EM
Eur J Epidemiol; 2014 Oct; 29(10):767-75. PubMed ID: 25154551
[TBL] [Abstract][Full Text] [Related]
4. A comment on 'the impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort'.
Choi NK; Chang Y; Park BJ
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1121-2. PubMed ID: 19852000
[No Abstract] [Full Text] [Related]
5. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
6. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
7. Acid-suppressive drugs and community-acquired pneumonia.
Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
[TBL] [Abstract][Full Text] [Related]
8. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
Hauben M; Horn S; Reich L; Younus M
Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population.
van de Garde EM; Souverein PC; van den Bosch JM; Deneer VH; Leufkens HG
Eur Respir J; 2006 Jun; 27(6):1217-22. PubMed ID: 16455828
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes.
van de Garde EM; Souverein PC; Hak E; Deneer VH; van den Bosch JM; Leufkens HG
J Hypertens; 2007 Jan; 25(1):235-9. PubMed ID: 17143196
[TBL] [Abstract][Full Text] [Related]
11. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
12. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
Etminan M; Zhang B; Fitzgerald M; Brophy JM
Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
14. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
Dial S; Delaney JA; Barkun AN; Suissa S
JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1173-82. PubMed ID: 22949094
[TBL] [Abstract][Full Text] [Related]
16. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia.
Mortensen EM; Pugh MJ; Copeland LA; Restrepo MI; Cornell JE; Anzueto A; Pugh JA
Eur Respir J; 2008 Mar; 31(3):611-7. PubMed ID: 17959631
[TBL] [Abstract][Full Text] [Related]
17. Risk of pneumonia in patients taking statins: population-based nested case-control study.
Vinogradova Y; Coupland C; Hippisley-Cox J
Br J Gen Pract; 2011 Nov; 61(592):e742-8. PubMed ID: 22054338
[TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
[TBL] [Abstract][Full Text] [Related]
19. Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.
Marciniak C; Korutz AW; Lin E; Roth E; Welty L; Lovell L
Am J Phys Med Rehabil; 2009 Jan; 88(1):30-8. PubMed ID: 19096289
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors: bacterial pneumonia.
Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
